What You Should Know:
– iCAD, Inc., a provider of clinically proven AI-powered breast health solutions, today announced the appointment of Mark Koeniguer as its Chief Commercial Officer (CCO).
– As CCO at iCAD, Koeniguer will oversee the commercial sales teams, strategic partnerships, operations, and customer success initiatives to drive revenue growth across North America and international markets.
Koeniguer Bio/Background
Mark Koeniguer joins iCAD with over 30 years of leadership experience in scaling MedTech, AI, and digital health companies. Most recently, he served as the Chief Executive Officer of ScreenPoint Medical, where he successfully transformed the company from a research-focused entity into a global commercial enterprise. During his tenure at ScreenPoint Medical, he achieved a remarkable 400% increase in annual recurring revenue and oversaw the launch of two FDA-cleared products.
Prior to his role at ScreenPoint Medical, Koeniguer held key executive leadership positions at prominent companies including Riverain Technologies, Volpara Health, R2 Technology, Stereotaxis, and GE Healthcare. Throughout his career, he has consistently demonstrated his ability to drive significant revenue growth and lead successful product launches in the medical technology space.
